Presentation TVT 2013 Pharmacotherapy Alternatives During and After TAVR: Is There an Optimal Regimen? Presenter: Corrado Tamburino June 12, 2013
Presentation TVT 2013 The Claret Montage Filter Device: Technology and Early Clinical Experiences Presenter: Eberhard Grube June 12, 2013
Presentation TVT 2013 An Anticoagulated Patient with Severe Paravalvular Regurgitation and Ostial Left Main Disease Presenter: Peter Pollak June 12, 2013
Presentation TVT 2013 Are Dedicated Transcutaneous LV Apical Access Closure Technologies Important to "Revive" the TA-TAVR Procedure? Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 The Keystone Deflector Device: Technology and Early Clinical Experiences Presenter: Jeffrey Moses June 12, 2013
Presentation TVT 2013 Early Clinical Experiences with the Apica TA-TAVR System Presenter: Joerg Kempfert June 12, 2013
Presentation TVT 2013 Defining and Measuring Frailty in Aortic Stenosis Patients: From the Eyeball Test to Objective Tools Presenter: Philip Green June 12, 2013
Presentation TVT 2013 Early Clinical Experiences with the Entourage TA-TAVR System Presenter: Raj Makkar June 12, 2013
Presentation TVT 2013 Risk Profiling Schemes Used in the US CoreValve Trial Presenter: Steven Yakubov June 12, 2013